Dem Rep. Kathy Manning scooped up thousands in chip company stock one day before voting to pass CHIPS Act
Democratic Rep. Kathy Manning purchased thousands in semiconductor company stock just one day before the House approved legislation providing massive subsidies to the sector.
Rivian shares rise, inflation check and more: Friday's 5 things to know
Investors will be looking closely at the third and final inflation report in the form of import & export prices for July.
Amazon worker deaths in New Jersey under investigation
Safety officials are investigating recent deaths at Amazon facilities in New Jersey, adding to a probe that was already underway.
Robinhood must face U.S. market manipulation claims over 'meme stock' rally, judge rules
Lawsuits allege Robinhood, GameStop and AMC violated laws in response to their social media driven stock rallies.
SEC investigating Melvin Capital Management
The SEC is investigating Melvin Capital Management's risk controls and investor disclosure after the hedge fund was crippled by the meme-stock rally last year.
Producer prices, Disney shares rise and more: Thursday's 5 things to know
Investors will be watching for the latest inflation figures in the form of producer prices as well as the latest jobless claims.
Nasdaq enters bull market, exits worst bear market since 2008
The beaten-down stock averages are dusting themselves off with the Nasdaq Composite entering a fresh bull market, while the Dow Jones Industrial Average exited its recent correction.
Fox posts higher revenue on ad sales strength
Fox Corp missed Wall Street quarterly revenue estimates
Retail prices, Sweetgreen plunges and more: Wednesday's 5 things to know
Investors will closely be watching for the release of the latest inflation numbers in the form of July's report on consumer prices. Earnings season will also continue Wednesday.
Coinbase reports loss amid crypto turmoil, shares fall
Coinbase shares fell in after-hours trading after the crypto exchange reported a loss for the second quarter. The company expects trading volumes in the current quarter to fall further.
Elon Musk sells nearly $7B in Tesla shares as Twitter legal battle rages on
Elon musk has sold nearly $7 billion worth of Tesla shares, months after saying he was done with his selling spree following his $44 billion bid to buy Twitter.
Bed Bath & Beyond downgrade slams stock
Investment firm Baird has placed an underperform rating and $4 price target on Bed Bath & Beyond's stock. The retailer's shares are down more than 36%.
Zales parent Signet Jewelers to buy online jewelry platform Blue Nile
The $360 million deal comes as Signet is looking to widen its portfolio and customer base following a sales slowdown in July.
Bed, Bath & Beyond stock on best nine day stretch on record
Meme investors are driving Bed, Bath & Beyond to its best nine-day stretch on record. The interest is also lifting other meme members, including AMC Entertainment and GameStop.
Stuart Varney: This is what you get when you stick with capitalism
FOX Business' Stuart Varney discusses the importance of capitalism and praises the "great bull market" as the Federal Reserve tries to combat rising inflation
SoftBank reports record $23B quarterly loss as tech downturn hits
SoftBank's record quarterly loss reflects the fall in technology shares around the world, sparked by interest rate increases and China's crackdown on tech firms.
Warren Buffett's Berkshire reports $44B loss as value of investments falls
Warren Buffett's Berkshire Hathaway suffered a $44 billion loss as a rocky quarter for the markets sent shares of the company's investments lower.
Elon Musk says Twitter deal could go forward once user data confirmed
Even as countersuits are served regarding Elon Musk's wanting to back out of deal to buy Twitter, the Tesla CEO says the deal could still go through.
Automakers say 70% of EV models don't qualify for tax credit under Senate bill
A majority of electric vehicles may not be eligible for tax credits under a Senate proposal due to parts requirements, a group of major automakers said.
Pfizer in advanced talks to buy Global Blood Therapeutics for about $5 billion
The Wall Street Journal reports big pharma company Pfizer is looking to add sickle-cell disease drugmaker Global Blood Therapeutics to its pipeline.



















